Daniel Grosslight
Stock Analyst at Citigroup
(1.05)
# 3,822
Out of 5,005 analysts
103
Total ratings
32.26%
Success rate
-15.87%
Average return
Main Sectors:
Stocks Rated by Daniel Grosslight
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MCK McKesson | Maintains: Buy | $820 → $860 | $738.06 | +16.52% | 8 | Sep 24, 2025 | |
| OMI Owens & Minor | Maintains: Buy | $11 → $7 | $4.76 | +47.06% | 7 | Aug 12, 2025 | |
| HCAT Health Catalyst | Downgrades: Neutral | $6.5 → $3.5 | $2.96 | +18.24% | 10 | Aug 8, 2025 | |
| AGL agilon health | Downgrades: Neutral | $3 → $1 | $1.13 | -11.50% | 6 | Aug 6, 2025 | |
| WAY Waystar Holding | Initiates: Buy | $45 | $38.64 | +16.46% | 1 | Jun 25, 2025 | |
| CAH Cardinal Health | Maintains: Neutral | $157 → $170 | $154.46 | +10.06% | 9 | Jun 13, 2025 | |
| HIMS Hims & Hers Health | Maintains: Sell | $25 → $30 | $52.54 | -42.90% | 11 | May 6, 2025 | |
| TDOC Teladoc Health | Maintains: Neutral | $11 → $8.75 | $9.01 | -2.89% | 11 | Apr 25, 2025 | |
| EVH Evolent Health | Maintains: Buy | $21 → $18 | $8.23 | +118.71% | 4 | Jan 10, 2025 | |
| GDRX GoodRx Holdings | Maintains: Buy | $7 → $6.25 | $4.53 | +37.97% | 7 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $35 | $23.27 | +50.41% | 6 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $24.09 | +3.78% | 1 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $10 | $4.44 | +125.23% | 7 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $7 → $8 | $11.22 | -28.70% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.5 → $1.25 | $2.10 | -40.48% | 5 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7 → $3.5 | $2.76 | +26.81% | 2 | Nov 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $9.09 | +43.01% | 1 | Dec 11, 2019 |
McKesson
Sep 24, 2025
Maintains: Buy
Price Target: $820 → $860
Current: $738.06
Upside: +16.52%
Owens & Minor
Aug 12, 2025
Maintains: Buy
Price Target: $11 → $7
Current: $4.76
Upside: +47.06%
Health Catalyst
Aug 8, 2025
Downgrades: Neutral
Price Target: $6.5 → $3.5
Current: $2.96
Upside: +18.24%
agilon health
Aug 6, 2025
Downgrades: Neutral
Price Target: $3 → $1
Current: $1.13
Upside: -11.50%
Waystar Holding
Jun 25, 2025
Initiates: Buy
Price Target: $45
Current: $38.64
Upside: +16.46%
Cardinal Health
Jun 13, 2025
Maintains: Neutral
Price Target: $157 → $170
Current: $154.46
Upside: +10.06%
Hims & Hers Health
May 6, 2025
Maintains: Sell
Price Target: $25 → $30
Current: $52.54
Upside: -42.90%
Teladoc Health
Apr 25, 2025
Maintains: Neutral
Price Target: $11 → $8.75
Current: $9.01
Upside: -2.89%
Evolent Health
Jan 10, 2025
Maintains: Buy
Price Target: $21 → $18
Current: $8.23
Upside: +118.71%
GoodRx Holdings
Jan 10, 2025
Maintains: Buy
Price Target: $7 → $6.25
Current: $4.53
Upside: +37.97%
Jan 10, 2025
Maintains: Buy
Price Target: $31 → $35
Current: $23.27
Upside: +50.41%
Apr 22, 2024
Initiates: Buy
Price Target: $25
Current: $24.09
Upside: +3.78%
Aug 9, 2023
Maintains: Neutral
Price Target: $9 → $10
Current: $4.44
Upside: +125.23%
Aug 4, 2023
Downgrades: Sell
Price Target: $7 → $8
Current: $11.22
Upside: -28.70%
Apr 28, 2023
Maintains: Neutral
Price Target: $1.5 → $1.25
Current: $2.10
Upside: -40.48%
Nov 16, 2021
Downgrades: Neutral
Price Target: $7 → $3.5
Current: $2.76
Upside: +26.81%
Dec 11, 2019
Initiates: Outperform
Price Target: $13
Current: $9.09
Upside: +43.01%